Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.

Daniyan O, Ezeanosike O, Obu D, Ujunwa F

Open source

DOI
10.34172/jcvtr.2022.03
Published
2022
Container
Journal of cardiovascular and thoracic research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/jcvtr.2022.03,
  title = {Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.},
  author = {Daniyan O and Ezeanosike O and Obu D and Ujunwa F},
  year = {2022},
  journal = {Journal of cardiovascular and thoracic research},
  doi = {10.34172/jcvtr.2022.03},
  url = {https://doi.org/10.34172/jcvtr.2022.03}
}

RIS

TY  - JOUR
TI  - Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.
AU  - Daniyan O
AU  - Ezeanosike O
AU  - Obu D
AU  - Ujunwa F
PY  - 2022
JO  - Journal of cardiovascular and thoracic research
DO  - 10.34172/jcvtr.2022.03
UR  - https://doi.org/10.34172/jcvtr.2022.03
ER  - 

APA

O, D., O, E., D, O., & F, U. (2022). Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.. Journal of cardiovascular and thoracic research. https://doi.org/10.34172/jcvtr.2022.03

Source records